Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Gynecologic Cancer Gynecologic Cancer for January/February 2021 ‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer, More must reads Gynecologic Cancer for November/December 2020 Is diagnostic hysteroscopy safe in patients with type 2 endometrial cancer?, Cervical cancer recurrence patterns differ after laparoscopic and open hysterectomy, Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest, Half of women treated for gynecologic cancers miss or skip doses of oral drugs, More must readsGynecologic Cancer for September/October 2020 Atezolizumab strikes out in ovarian cancer, Palbociclib plus letrozole improves PFS in advanced endometrial cancer, Gene signature may improve prognostication in ovarian cancer, More must readsGynecologic Cancer for July/August 2020 ACS disagrees with CDC on HPV vaccination in adults, How often does risk-reducing salpingo-oophorectomy identify cancer?, Lipophilic statins linked to lower mortality in ovarian cancer, More must readsGynecologic Cancer for May/June 2020 Sequential chemoradiation improves DFS in early-stage cervical cancer, Vulvar melanoma is increasing in older women, Secondary surgery extends OS in recurrent ovarian cancer, One strikeout, one hit against low-grade serous carcinomas, Vaccine maintenance improves relapse-free survival in BRCA wild-type ovarian cancer, More must readsPages1 2 3 4 5 6 7 last »
